U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number: 001-14297
Notification of Late Filing
(Check One):
[ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-QSB
[ ] Form N-SAR
For Period Ended: March 31, 2003
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: N/A
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
Part I - Registrant Information
-------------------------------
MW Medical, Inc.
----------------
Full Name of Registrant
Not Applicable
--------------
Former Name if Applicable
6929 E. Cheney
--------------
Address of Principal Executive Office (Street and Number)
Paradise Valley, Arizona 85253
------------------------------
City, State and Zip Code
Part II - Rules 12b-25(b) and (c)
---------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-(b), the following should
be completed. (Check box, if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N- SAR, or portion thereof will be filed on
or before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III - Narrative
--------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be file within
the prescribed period.
Management was unable to obtain necessary business information in time for
filing. Such information is required in order to prepare a complete filing.
Part IV - Other Information
---------------------------
(1) Name and telephone number of person to contract in regard to this
notification.
Michael A. Cane (702) 312-6255
- --------------- ----- --------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[ ] Yes [ X ] No
The Company has not filed a Form 10-KSB for the fiscal year ended December 31,
2002.
2
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Completed financial information for the twelve-months ending December 31, 2002
has not yet been confirmed. The net loss for the nine-months ended September 30,
2002 was approximately $406,528 compared to a loss of $1,764,053 during the same
period in 2001. General and administrative expenses for the nine-months ended
September 30, 2002 were approximately $326,408 compared to $623,311 for the same
period in 2001.
MW MEDICAL, INC.
----------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: May 15, 2003 By:
/s/ Jan Wallace
_________________________
Jan Wallace
President & Director
3